IGF1 and myocardial infarction: For example, alginate hydrogels engineered for the sequential release of IGF-1 and hepatocyte growth factor (HGF) reduced cardiomyocyte apoptosis, minimized infarct size, and improved ventricular remodeling and function in rat MI models [182].